The von Willebrand factor collagen-binding activity assay: Clinical application

Annals of Hematology

Volumn 80, Issue 8, 2001, Pages 466-471

  Kallas, A ^a   Talpsep, T ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Collagen; Factor VIII; Factor VIII concentrate; Von Willebrand factor; Von Willebrand's disease

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; COLLAGEN TYPE 3; DESMOPRESSIN; HAEMATE; HAEMOCTIN SDH; KRYO AHG; RISTOCETIN; VON WILLEBRAND FACTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASSAY; BLOOD GROUP O; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TIME; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

COLLAGEN; DEAMINO ARGININE VASOPRESSIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VII; HUMANS; REFERENCE VALUES; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0034882691     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770100329     Document Type: Article

References (29)

1. Screening of factor VIII:C levels in blood donors
2. Abnormal collagen binding activity of 2A von Willebrand factor: Evidence that the effect depends only on the lack of large multimers
3. Which assay is the most suitable to investigate von Willebrand factor functional activity?
4. Interaction of the von Willebrand factor (VWF) with collagen
5. Human coagulation factor VIII, freeze-dried
6. Assay of ristocetin co-factor using fixed platelets and a platelet counting technique
7. Collagen binding assay for von Willebrand factor (VWF:CBA): Detection of von Willebrand's disease (VWD), and discrimination of VWF subtypes, depends on collagen source
8. Discrimination of von Willebrand's disease (VWD) subtypes: Direct comparison von Willebrand factor collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems
9. Collagen covalently immobilized onto plastic surfaces simplifies measurement of von Willebrand factor-collagen binding activity
10. Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers
11. The effect of ABO blood group on the diagnosis of von Willebrand disease
12. Von Willebrand factor binds to native collagen VI primarily via its A1 domain
13. Crystal structure of the A3 domain of human von Willebrand factor: Implications for collagen binding
14. A method for assaying von Willebrand factor (ristocetin cofactor)
15. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor
16. The relationship between coagulation factor VIII and ABO blood group status
17. Clinical pharmacokinetics of factor VIII in patients with classic haemophilia
18. Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand multimer analysis
19. Type 1 von Willebrand disease - A clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history
20. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III
21. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay
22. The von Willebrand factor
23. Epidemiological investigation of the prevalence of von Willebrand's disease
24. Biochemistry and genetics of von Willebrand factor
25. Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor
26. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets
27. The determination of von Willebrand factor activity by collagen binding assay
28. Adhesive domains in the collagen III fragment α1(III)CB4 that supports α2β1- and von Willebrand factor-mediated platelet adhesion under flow conditions
29. Von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies